Interleukin-1α Activity in Necrotic Endothelial Cells Is Controlled by Caspase-1 Cleavage of Interleukin-1 Receptor-2: IMPLICATIONS FOR ALLOGRAFT REJECTION.

The Journal of Biological Chemistry
Laura C BurzynskiMurray C H Clarke

Abstract

Inflammation is a key instigator of the immune responses that drive atherosclerosis and allograft rejection. IL-1α, a powerful cytokine that activates both innate and adaptive immunity, induces vessel inflammation after release from necrotic vascular smooth muscle cells (VSMCs). Similarly, IL-1α released from endothelial cells (ECs) damaged during transplant drives allograft rejection. However, IL-1α requires cleavage for full cytokine activity, and what controls cleavage in necrotic ECs is currently unknown. We find that ECs have very low levels of IL-1α activity upon necrosis. However, TNFα or IL-1 induces significant levels of active IL-1α in EC necrotic lysates without alteration in protein levels. Increased activity requires cleavage of IL-1α by calpain to the more active mature form. Immunofluorescence and proximity ligation assays show that IL-1α associates with interleukin-1 receptor-2, and this association is decreased by TNFα or IL-1 and requires caspase activity. Thus, TNFα or IL-1 treatment of ECs leads to caspase proteolytic activity that cleaves interleukin-1 receptor-2, allowing IL-1α dissociation and subsequent processing by calpain. Importantly, ECs could be primed by IL-1α from adjacent damaged VSMCs, and necr...Continue Reading

References

Oct 1, 1994·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·P LoetscherB Moser
Oct 28, 1998·Archives of Ophthalmology·J YamadaJ W Streilein
May 5, 2001·Immunity·P Libby, J S Pober
Dec 22, 2006·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Eleonora SimeoniGiuseppe Vassalli
Nov 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Deepak A RaoJordan S Pober
Mar 15, 2008·Nature Reviews. Immunology·Hajime Kono, Kenneth L Rock
Mar 24, 2009·Annual Review of Immunology·Charles A Dinarello
Dec 29, 2009·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Tatsuichiro SetoKen-ichi Ito
Nov 8, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M McCallA M J Shapiro
Nov 19, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Yue ZhengMurray C H Clarke

❮ Previous
Next ❯

Citations

Aug 21, 2019·Journal of Thrombosis and Haemostasis : JTH·Edward M Conway
Oct 16, 2019·The Journal of Experimental Medicine·Amy H Chan, Kate Schroder
Jun 2, 2017·The Journal of Clinical Investigation·S Samuel WeigtJohn A Belperio

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
PCR
Assay
flow cytometry
proximity ligation assay
proximity ligation
proximity
transfection

Software Mentioned

Excel
CellD
DuoLink

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Caspases in Metabolic Diseases

Caspases, the family of cysteine proteases are involved in programmed cell death, but their role in metabolic diseases, inflammation and immunity has been of interested. Discover the latest research on caspases in metabolic diseases here.